Pfizer: Psoriasis trials

The registry lists 57 Psoriasis studies with Pfizer as lead sponsor. 0 are open to participants now and 46 have results posted.

Phase 1 10Phase 2 13Phase 3 10Phase 4 9No phase 15(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or PsoriasisCompletedNCT05796245Results posted
• Study To Evaluate The Impact Of Difficult To Treat Sites On Biological Response In Moderate-To-Severe Plaque Psoriasis(PsO).CompletedNCT04428411Results posted
• Study to Evaluate the Efficacy of Enbrel as a Biological Treatment in Moderate to Severe Plaque Psoriasis PatientsCompletedNCT04398732Results posted
• A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque PsoriasisCompletedNCT03895372Phase 2Results posted
• Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In PsoriasisCompletedNCT03850483Phase 2Results posted
• Safety, Tolerability And Efficacy Study Of Topical PF-06763809 In Subjects With Mild To Moderate Chronic Plaque PsoriasisCompletedNCT03469336Phase 1Results posted
• A First in Human Study to Evaluate Safety, Tolerability, and Pharmacology of PF-06826647 in Healthy Subjects and Subjects With Plaque PsoriasisCompletedNCT03210961Phase 1Results posted
• Study To Evaluate Safety And Efficacy Of PF-06700841 In Subjects With Moderate To Severe Plaque PsoriasisCompletedNCT02969018Phase 2Results posted
• The Effect Of Smoking Status Of The Patient On The Success Of Etanercept Therapy In PsoriasisCompletedNCT02570750Results posted
• A Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06700841, With Bioavailability/Food Effect InvestigationCompletedNCT02310750Phase 1Results posted
• Study to Evaluate PF-04965842 in Patients With Moderate to Severe PsoriasisTerminatedNCT02201524Phase 2Results posted
• A 12 Day Study To Evaluate A Topical Drug To Treat Plaque PsoriasisCompletedNCT02193815Phase 1Results posted
• Open-Label Extension Study Of Tofacitinib In Psoriatic ArthritisCompletedNCT01976364Phase 3Results posted
• Tofacitinib Ointment For Chronic Plaque PsoriasisCompletedNCT01831466Phase 2Results posted
• A Study Evaluating The Efficacy And Safety Of CP-690,550 In Asian Subjects With Moderate To Severe Plaque PsoriasisCompletedNCT01815424Phase 3Results posted
• Multiple Dose Escalation Study In Medically Stable Subjects With PsoriasisCompletedNCT01736696Phase 1Results posted
• Study Of The Mechanism Of Action Of CP-690,550 In The Skin Of Subjects With Moderate To Severe Chronic Plaque PsoriasisCompletedNCT01710046Phase 2Results posted
• An Observational Study of the Real Life Management of the Psoriasis Patients Treated With Enbrel According to the New Reimbursement CriteriaCompletedNCT01557283Results posted
• A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic ArthritisCompletedNCT01519089Phase 3Results posted
• A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque PsoriasisCompletedNCT01309737Phase 3Results posted
• AN2728 Topical Ointment to Treat Mild-to-Moderate Plaque-Type PsoriasisCompletedNCT01300052Phase 2Results posted
• A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque PsoriasisCompletedNCT01276639Phase 3Results posted
• CP-690-550 Ointment For Chronic Plaque PsoriasisCompletedNCT01246583Phase 2Results posted
• A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque PsoriasisCompletedNCT01241591Phase 3Results posted
• A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque PsoriasisCompletedNCT01186744Phase 3Results posted
• A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque PsoriasisTerminatedNCT01163253Phase 3Results posted
• Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology PracticeCompletedNCT01147874Phase 4Results posted
• Study Evaluating the Safety and Effectiveness of Etanercept for the Treatment of Pediatric PsoriasisCompletedNCT01100034Results posted
• Safety and Efficacy Study of a Novel Ointment to Treat Plaque Type PsoriasisCompletedNCT01029405Phase 2Results posted
• Study Evaluating Single Dose Of ILV-095 In Psoriasis SubjectsTerminatedNCT01010542Phase 1Results posted
• Study Comparing 2 Different Strategies For Management of Subjects With Plaque Psoriasis Who Have Responded to EtanerceptCompletedNCT00992394Phase 4Results posted
• Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe PsoriasisCompletedNCT00936065Phase 4Results posted
• Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type PsoriasisCompletedNCT00759161Phase 2Results posted
• Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type PsoriasisCompletedNCT00755196Phase 2Results posted
• Observational Study Evaluating Etanercept (Enbrel®) In Subjects With Plaque-Type Psoriasis In Usual Care SettingsCompletedNCT00708708Results posted
• Topical CP-690,550 For Chronic Plaque PsoriasisCompletedNCT00678561Phase 2Results posted
• Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT00678210Phase 2Results posted
• Study Evaluating Etanercept for the Treatment of Moderate to Severe PsoriasisCompletedNCT00663052Phase 4Results posted
• Evaluation of Etanercept in Patients With Plaque Psoriasis After Stopping Ciclosporin TherapyCompletedNCT00581555Phase 4Results posted
• Effects of Etanercept on Nail Psoriasis and Plaque PsoriasisCompletedNCT00581100Phase 4Results posted
• Study Evaluating The Safety And Tolerability Of ILV-094 In Subjects With PsoriasisCompletedNCT00563524Phase 1Results posted
• Compare Perceptions and Satisfaction for Two Different Delivery Mechanisms for EtanerceptCompletedNCT00482170Phase 3Results posted
• Study Evaluating the Cost of the Treatments of the Refractory Psoriatic Arthritis to the Conventional TherapyCompletedNCT00303186Results posted
• Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by RheumatologistsCompletedNCT00293722Results posted
• Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by DermatologistsCompletedNCT00293709Results posted
• Study Evaluating Etanercept in the Treatment of Subjects With PsoriasisCompletedNCT00195507Phase 4Results posted
• Post Marketing Surveillance To Observe Safety And Efficacy Of Enbrel In Pediatric Patients With PsoriasisWithdrawnNCT01432249
• Systematic Review And Meta-Analysis Of Psoriasis Treatments.CompletedNCT01425138
• Safety Study of Ointment for the Treatment of Plaque-type PsoriasisCompletedNCT01258088Phase 1
• Study Evaluating The Prevalence Of Undiagnosed Psoriatic Arthritis In Patients With Plaque PsoriasisCompletedNCT00998829
• Study Evaluating Management of Patients With Moderate and Severe PsoriasisCompletedNCT00894777
• A Phase I Study to Assess Novel Cream in a Psoriasis Plaque TestCompletedNCT00763204Phase 1
• A Phase I Study to Assess Novel Ointment in a Psoriasis Plaque TestCompletedNCT00762658Phase 1
• Study Evaluating Safety of Etanercept in Treatment of Patients With Moderate to Severe Psoriasiswith EtanerceptCompletedNCT00581165Phase 4
• Study Evaluating the Safety and Efficacy of Etanercept 50 mg Once Weekly in Subjects With PsoriasisCompletedNCT00333034Phase 3
• Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque PsoriasisCompletedNCT00227240
• Study Evaluating Etanercept and Methotrexate in Plaque PsoriasisCompletedNCT00161655Phase 4